RBP4 and liver dysplastic nodule: Therefore, investigation of the diagnostic value of RBP4 as a biomarker for early detection of DN needs a large sample, with blinding and randomization, using a unified detection method for DN staging, so that the authenticity and reliability of the analysis are more clinically meaningful.